111 related articles for article (PubMed ID: 11360189)
1. Absence of PPP2R1A mutations in Wilms tumor.
Ruteshouser EC; Ashworth LK; Huff V
Oncogene; 2001 Apr; 20(16):2050-4. PubMed ID: 11360189
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
3. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
[TBL] [Abstract][Full Text] [Related]
4. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
[TBL] [Abstract][Full Text] [Related]
5. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
6. Absence of PPP2R1B gene alterations in primary ovarian cancers.
Campbell IG; Manolitsas T
Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
[TBL] [Abstract][Full Text] [Related]
7. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
8. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
9. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
11. WT1 splicing alterations in Wilms' tumors.
Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetics of Wilms' tumor].
Papezová M; Mares J; Goetz P
Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
14. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
15. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
16. Familial extrarenal Wilms tumor.
Houben CH; Tong JH; Chan AW; Chik KW; Lee KH; Sihoe JD; Tam YH; Yeung CK
J Pediatr Surg; 2007 Nov; 42(11):1826-30. PubMed ID: 18022431
[TBL] [Abstract][Full Text] [Related]
17. Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer.
Wang F; Zou Y; Liu FY; Yu XH; Huang H; Zhang N; Qi YY; Liu RF; Liu XY; Chen J; Huang OP; He M
Mol Med Rep; 2013 Jun; 7(6):1826-30. PubMed ID: 23588898
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
19. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
20. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]